Document Detail


PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier.
MedLine Citation:
PMID:  20553983     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Due to the existence of the blood-spinal cord barrier (BSCB), many therapeutic macromolecular agents, such as drugs, protein and gene, cannot pass through this barrier to reach the site of injury, all of which restricts the treatment of spinal cord injuries (SCI). In this study, TAT-conjugated PEGlated Magnetic polymeric liposomes (TAT-PEG-MPLs) formed from PEGlated amphiphilic octadecyl quaternized carboxymethyl chitosan (PEG-OQCMC), cholesterol (Chol), superparamagnetic nanoparticles, and transactivating-transduction protein (TAT), were prepared successfully and evaluated the properties in vitro and in vivo. The result indicated that TAT-PEG-MPLs were spherical in solution, with significantly small mean diameter (83.2 nm) and excellent magnetism (magnetization saturation values of 43.5 emu/g). In vitro experiment, the uptake of PEG-MPLs with TAT by MCF-7 cells was greater than that of the PEG-MPLs without TAT. Most importantly, in vivo experiment, a low MRI signal was observed in the T(2)-weighted images; Histological analysis, Cryo-TEM and flame atomic absorption spectrophotometry revealed that TAT-PEG-MPLs nanoparticles significantly accumulated around the site of the SCI even inside the nerve cells. These nanoparticles may provide a promising carrier to locate to the lesion site, deliver therapeutic macromolecular agents across the BSCB and penetrate into the nerve cells for the treatment of SCI.
Authors:
Hanjie Wang; Shuangnan Zhang; Zhenyu Liao; Chunyuan Wang; Yang Liu; Shiqing Feng; Xinguo Jiang; Jin Chang
Related Documents :
17894633 - Spinal cord pilomyxoid astrocytoma: an unusual tumor.
20354473 - The relationship between magnetic resonance imaging and quantitative electromyography f...
20567963 - Anterior lateral meniscofemoral ligament with congenital absence of the acl.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biomaterials     Volume:  31     ISSN:  1878-5905     ISO Abbreviation:  Biomaterials     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-07-08     Completed Date:  2010-10-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100316     Medline TA:  Biomaterials     Country:  England    
Other Details:
Languages:  eng     Pagination:  6589-96     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Institute of Nanobiotechnology, School of Materials Science and Engineering, Tianjin University and Tianjin Key Laboratory of Composites and Functional Materials, Tianjin 300072, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Gene Products, tat / chemistry,  pharmacokinetics*
Liposomes / chemistry,  pharmacokinetics*
Magnetic Resonance Imaging
Magnetics
Polyethylene Glycols / chemistry,  pharmacokinetics*
Polymers / chemistry,  pharmacokinetics
Rats
Spinal Cord / metabolism*
Spinal Cord Injuries / drug therapy,  pathology*
Surface Properties
Chemical
Reg. No./Substance:
0/Gene Products, tat; 0/Liposomes; 0/Polyethylene Glycols; 0/Polymers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lipid-based nanoparticles with high binding affinity for amyloid-beta(1-42) peptide.
Next Document:  The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticula...